Indeed, pharmacological blockade of mPFC-mGluR5 in our chronic neuropathic pain model animal was sufficient to relieve the both of the nerve injury-induced pain and the depression symptoms which are experimentally assessed by paw withdrawal threshold in von Frey test and immobility time in FST respectively. This evidence concerns the gene GRM5 and major depressive disorder.